| 英文名称 |
中文名称 |
CAS |
|
Erlotinib Impurity H
|
厄洛替尼杂质H |
183320-12-9 |
|
Lidocaine N-oxide
|
利多卡因 N-氧化物 |
2903-45-9 |
|
Paliperidone Impurities1
|
帕利哌酮杂质1 |
260273-82-3 |
|
(S)-Cetirizine DiHCl
|
(S)-二盐酸西替利嗪 |
163837-48-7 |
|
Risperidone EP Impurity K
|
利培酮杂质K |
106266-09-5 |
|
Afatinib Impurity3
|
阿法替尼杂质3 |
314771-88-5 |
|
(R)-Linezolid
|
(R)-利奈唑胺 |
872992-20-6 |
|
Enalaprilat Benzyl Ester
|
依那普利拉苄酯 |
76391-33-8 |
|
Azilsartan medoxomil Impurity I
|
阿齐沙坦杂质I |
139481-33-7 |
|
Pioglitazone Aldehyde Impurity
|
吡格列酮醛杂质 |
856255-80-6 |
|
Enalaprilat EP Impurity B (RSS Isomer)
|
依那普利拉杂质B(RSS 异构体) |
196083-21-3 |
|
Lidocaine Impurity 4
|
利多卡因杂质4 |
857170-05-9 |
|
O-Desmethyl Gefitinib
|
O-去甲基吉非替尼 |
847949-49-9 |
|
Nimodipine Impurity 1
|
尼莫地平杂质1 |
82219-47-4 |
|
Pioglitazone Bromo Impurity
|
吡格列酮溴杂质 |
669716-58-9 |
|
Pioglitazone Sulfonic Impurity
|
吡格列酮磺酸杂质 |
625853-73-8 |
|
Felodipine EP Impurity B
|
非洛地平EP杂质B |
91189-59-2 |
|
Clevidipine Impurity 6
|
氯维地平杂质6 |
138279-32-0 |
|
Paliperidone Impurity I
|
帕利哌酮杂质I |
|
|
Hydroxy Pioglitazone M-IV
|
羟基吡格列酮 M-IV |
146062-44-4 |
|
Gefitinib Impurity16
|
吉非替尼杂质 16 |
153437-78-6 |
|
Azilsartan medoxomil Impurity F
|
阿齐沙坦杂质F |
1863930-34-0 |
|
trans-Risperidone N-Oxide
|
利培酮反式N-氧化物 |
1200448-51-6 |
|
Paliperidone amide impurities
|
帕利哌酮酰胺杂质 |
1006685-69-3 |
|
Clopidogrel Impurities3
|
氯吡格雷杂质3 |
141315-50-6 |
|
Arbidol Impurity 1
|
阿比朵尔杂质1 |
1130901-04-0 |
|
Clopidogrel Impurities2
|
氯吡格雷杂质2 |
1346231-35-3 |
|
Pioglitazone EP Impurity C
|
吡格列酮杂质C |
952188-00-0 |
|
Enalapril EP Impurity F
|
依那普利杂质F |
76420-77-4 |
|
Paliperidone Impurities2
|
帕利哌酮杂质2 |
849903-79-3 |
|
Ziprasidone Impurity 1
|
齐拉西酮杂质1 |
884305-06-0 |
|
Clevidipine Impurity 3
|
氯维地平杂质3 |
193539-61-6 |
|
Afatinib Impurity9
|
阿法替尼杂质9 |
2413212-17-4 |
|
Pioglitazone Impurity 4
|
吡格列酮杂质4 |
1526933-30-1 |
|
Indobufen Impurity 11
|
吲哚布芬杂质11 |
858847-40-2 |
|
Arbidol Impurity 6
|
阿比朵尔杂质6 |
110543-98-1 |
|
Lidocaine Impurity 7
|
利多卡因杂质7 |
18865-38-8 |
|
Paliperidone Impurities3
|
帕利哌酮杂质3 |
95742-20-4 |
|
Cetirizine Impurity G
|
西替利嗪杂质G |
728948-88-7 |
|
Risperidone Related Compound G
|
利培酮相关化合物 G |
152542-00-2 |
|
LCZ696 impurities2
|
LCZ696杂质2 |
1012341-48-8 |
|
Linezolid Impurity6
|
利奈唑胺杂质6 |
2180529-06-8 |
|
Paliperidone Impurity H
|
帕利哌酮杂质H |
1388021-47-3 |
|
Ziprasidone EP Impurity A HCl
|
盐酸齐拉西酮杂质A |
87691-88-1 |
|
Arbidol Impurity 5
|
阿比朵尔杂质5 |
2107765-51-3 |
|
Dabigatran Impurity 02
|
达比加群杂质 02 |
1253792-34-5 |
|
Pioglitazone N-Oxide
|
吡格列酮 N-氧化物 |
145350-09-0 |
|
alogliptin impurities2
|
阿格列汀杂质2 |
2565-47-1 |
|
Risperidone EP Impurity A and B (Mixture of E and Z Isomers)
|
利培酮 EP 杂质 A 和 B(E 和 Z 异构体的混合物) |
158697-66-6 |
|
Clevidipine Impurity 1
|
氯维地平杂质1 |
253597-19-2 |
|
Lidocaine Dichloro Impurity
|
利多卡因二氯杂质 |
39084-88-3 |
|
Levocetirizinamide
|
左西替利嗪酰胺 |
909779-33-5 |
|
Paliperidone 9-Keto Impurity
|
帕潘立酮 9-酮杂质 |
1189516-65-1 |
|
alogliptin impurities9
|
阿格列汀杂质9 |
865758-96-9 |
|
Risperidone Impurity 1
|
利培酮杂质1 |
439082-09-4 |
|
Enalapril EP Impurity E
|
依那普利杂质E |
|
|
Lidocaine EP Impurity D
|
利多卡因杂质D |
7729-94-4 |
|
Paliperidone E-Oxime
|
帕潘立酮E-异构体 |
1388021-46-2 |
|
Sorafenib impurities6
|
索拉非尼杂质6 |
2004659-84-9 |
|
Nimodipine EP Impurity A
|
尼莫地平杂质A |
85677-93-6 |
|
Linezolid Impurity8
|
利奈唑胺杂质8 |
168828-82-8 |
|
Erlotinib Lactam Impurity
|
厄洛替尼内酰胺杂质 |
179688-29-0 |
|
Arbidol Impurity 8
|
阿比朵尔杂质8 |
1312943-26-2 |
|
Indobufen Impurity 7
|
吲哚布芬杂质7 |
1093759-05-7 |
|
Risperidone EP Impurity A
|
利培酮杂质A |
691007-09-7 |
|
3'-Hydroxy Lidocaine
|
3'-羟基利多卡因 |
34604-55-2 |
|
Pioglitazone EP Impurity A
|
吡格列酮EP杂质A |
625853-74-9 |
|
6-Desfluoro-6-Hydroxy Risperidone
|
6-去氟-6-羟基利培酮 |
106266-11-9 |
|
Paliperidone Impurities12
|
帕利哌酮杂质12 |
181525-38-2 |
|
Dabigatran etexilate impurity9
|
达比加群酯杂质9 |
1702936-92-2 |
|
LCZ696 impurities537-06
|
LCZ696杂质537-06 |
1038924-70-7 |
|
Linezolid Impurity 20
|
利奈唑胺杂质20 |
1215006-08-8 |
|
Risperidone Impurity 2
|
利培酮杂质2 |
108855-18-1 |
|
Arbidol Impurity 3
|
阿比朵尔杂质3 |
153633-10-4 |
|
Lidocaine Impurity 9
|
利多卡因杂质9 |
131081-28-2 |
|
Dabigatran Impurity 03
|
达比加群杂质 03 |
1899045-28-3 |
|
Lidocaine EP Impurity D
|
利多卡因杂质D |
7728-40-7 |
|
clevidipine acid
|
氯维地平酸 |
123853-39-4 |
|
Ziprasidone EP Impurity E
|
齐拉西酮杂质E |
1159977-04-4 |
|
Ziprasidone EP Impurity C
|
齐拉西酮杂质C |
1159977-64-6 |
|
Pioglitazone EP IMpurity G
|
吡格列酮杂质G |
952187-99-4 |
|
Arbidol Sulfone
|
阿比朵尔砜 |
151455-32-2 |
|
Paliperidone Palmitate
|
帕利哌酮棕榈酸酯 |
199739-10-1 |
|
Lidocaine Impurity 3
|
利多卡因杂质3 |
2903-48-2 |
|
Gefitinib N-Oxide
|
吉非替尼 N-氧化物 |
847949-51-3 |
|
Sorafenib impurities5
|
索拉非尼杂质5 |
1129683-83-5 |
|
Nimodipine EP Impurity B
|
尼莫地平杂质B |
21881-78-7 |
|
Clevidipine Impurity 7
|
氯维地平杂质7 |
253597-20-5 |
|
Indobufen Impurity 10
|
吲哚布芬杂质10 |
94814-82-1 |
|
Indobufen Impurity 15
|
吲哚布芬杂质15 |
94232-67-4 |
|
Indobufen Impurity 5
|
吲哚布芬杂质5 |
29644-97-1 |
|
Risperidone EP Impurity E
|
利培酮杂质E |
1346602-28-5 |
|
Levocetirizine Impurity 1
|
左西替利嗪杂质1 |
1391053-09-0 |
|
Lidocaine EP Impurity E
|
利多卡因杂质E |
745798-07-6 |
|
Lidocaine EP Impurity F
|
利多卡因杂质F |
857170-72-0 |
|
Paliperidone Impurity J
|
帕利哌酮杂质J |
|
|
Ziprasidone related substance F
|
齐拉西酮有关物质F |
684269-12-3 |
|
Dabigatran etexilate impurity1
|
达比加群酯杂质1 |
58906-64-2 |
|
Paliperidone Impurities9
|
帕利哌酮杂质9 |
1172995-11-7 |
|
2-(4-Nitrophenyl)butyric acid
|
2-(4-硝基苯基)丁酸 |
7463-53-8 |